Christopher Vandepas serves as the Senior Director of Program Management at SAGA Diagnostics, having transitioned from a successful role as Director of Portfolio Program Management at Guardant Health. With over 15 years of experience in portfolio, program, and project management, including nearly a decade in the medical device industry, Christopher specializes in the Oncology sector. Previous roles include Associate Director of Portfolio Management and Project Manager at DiaSorin Molecular LLC, where significant revenue growth and successful project implementations were achieved. Christopher's educational background includes studies in Cognitive Project Management in AI and certifications in Marketing Innovation and Leadership from prestigious institutions such as MIT and Stanford University.
This person is not in any teams
This person is not in any offices